title: Advances in treating chronic lymphocytic leukemia.
abstract: Chronic lymphocytic leukemia (CLL) is the most prevalent type of leukemia, affects mostly elderly CLL patients, and is incurable without allogeneic transplantation. Although classic chemo(immuno)therapy is still the standard of care for patients in need of treatment, this paradigm might change in the near future with the advent of new therapeutic agents targeting major pathogenic pathways in CLL.
authors.affiliation: Ulm University, Department of Internal Medicine III Albert-Einstein-Allee 23, 89081 Ulm Germany.
authors.forename: Eugen
authors.initials: E
authors.lastname: Tausch
authors.affiliation: Ulm University, Department of Internal Medicine III Albert-Einstein-Allee 23, 89081 Ulm Germany ; Cooperation Unit 'Mechanisms of Leukemogenesis' German Cancer Research Center (DKFZ), INF280, 69120 Heidelberg Germany.
authors.forename: Daniel
authors.initials: D
authors.lastname: Mertens
authors.affiliation: Ulm University, Department of Internal Medicine III Albert-Einstein-Allee 23, 89081 Ulm Germany.
authors.forename: Stephan
authors.initials: S
authors.lastname: Stilgenbauer